As part of the PDAOAI initiative, Oncotelic has curated a comprehensive TGF-β literature corpus comprising more than 125,000 PubMed abstracts, representing the near-totality of scientific knowledge ...

T-MAXIMUM is currently focused on late-stage malignant tumors, and its lead program for recurrent glioma has received clearance to enter Phase II clinical trials. Over the next three years, the ...

The gross proceeds to the Company from this offering are expected to be approximately $3.2 million, before deducting the placement agent's fees and other offering expenses payable by the Company. The ...

After patient deaths from interstitial lung disease in a lung cancer trial testing the antibody-drug conjugate ifinatamab deruxtecan, the FDA placed a partial hold on Daiichi Sankyo and Merck's global ...

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the ...

A study by Case Western Reserve University and University Hospitals researchers has overturned long-held assumptions about why more cancer patients don't enroll in clinical trials that could ...

A study by Case Western Reserve University and University Hospitals researchers has overturned long-held assumptions about ...

Introduction Nasogastric tubes (NGTs) are standard practice in the management of adhesive small bowel obstruction (ASBO). Their insertion can be associated with significant patient discomfort and ...

A treatment for alopecia areata could move forward despite a setback in a midstage clinical trial.

Med’s registry platform will work alongside WellSky’s network of home-based care organizations to let patients participate in ...

WellSky and uMed have announced a strategic partnership that expands patient access to national clinical research registries – longitudinal programs that track real-world ...

Physicians stand to earn big money when signing up patients for drug trials. And lately, some of those trials have been ...